Colgate-Palmolive grants options to CLO Fishbone

Colgate-Palmolive’s CLO and Secretary received new stock option and RSU grants, increasing her direct and indirect equity holdings in the company.

Rhea-AI Filing Summary

COLGATE PALMOLIVE CO (CL) reported that its CLO and Secretary, Betsy Fishbone, received equity awards on September 16, 2026. She was granted a stock option for 15,271 shares of common stock at an exercise price of $87.02 per share, expiring September 16, 2036, which becomes exercisable in one-third increments beginning on the first anniversary of the grant date.

She also received a restricted stock unit award of 2,207 shares that vests in equal one-third installments on each of the first, second, and third anniversaries of the grant date, increasing her directly held common stock to 16,050 shares. In addition, 50 common shares are held indirectly by a family member and 8,336 common shares are held indirectly through the issuer's 401(k) plan trustee.

Insider Trade Summary

Grant/Award: 17,478 shares

Grant/Award 4 txns

Insider Fishbone Betsy

Role CLO and Secretary

Type	Security	Shares	Price	Value
Grant/Award	Stock Option (Right to Buy) F2, F3	15,271	$0.00	$0.00
Grant/Award	Common Stock F1	2,207	$0.00	$0.00
holding	Common Stock	--	--	--
holding	Common Stock	--	--	--

Holdings After Transaction: Stock Option (Right to Buy) — 15,271 contracts (Direct); Common Stock — 16,050 shares (Direct); Common Stock — 50 shares (Indirect, By Family Member); Common Stock — 8,336 shares (Indirect, By Issuer's 401(k) Plan Trustee)

Footnotes (3)

1. F1. Restricted stock unit award granted under the issuer's incentive compensation plan. The restricted stock unit award vests in equal 1/3 installments on each of the first, second and third anniversary of the date of grant.
2. F2. Stock option award granted under the issuer's incentive compensation plan.
3. F3. Option becomes exercisable in one-third increments beginning on the first anniversary of the September 16, 2026 grant date.

Key Figures

Stock options granted: 15,271 shares Stock option exercise price: $87.02 per share Stock option expiration: September 16, 2036 +4 more

7 metrics

Stock options granted 15,271 shares Stock option award to CLO and Secretary on September 16, 2026

Stock option exercise price $87.02 per share Exercise price for 15,271-share stock option grant

Stock option expiration September 16, 2036 Expiration date of the stock option grant

Restricted stock units granted 2,207 shares RSU award vesting over three years from September 16, 2026

Direct common shares after transactions 16,050 shares Direct Colgate-Palmolive common stock holdings reported after grants

Indirect family holdings 50 shares Common stock held indirectly by a family member

Indirect 401(k) plan holdings 8,336 shares Common stock held indirectly by issuer's 401(k) plan trustee

Key Terms

Restricted stock unit, Incentive compensation plan, Stock option, 401(k) Plan Trustee

4 terms

Restricted stock unit financial

"Restricted stock unit award granted under the issuer's incentive compensation plan."

A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.

Incentive compensation plan financial

"award granted under the issuer's incentive compensation plan."

An incentive compensation plan is a formal program that rewards employees and executives with bonuses, stock, or other payments tied to specific performance goals—such as revenue, profit, productivity, or long‑term share price. Investors watch these plans because they shape how leaders make decisions and take risks; like paying a coach by wins rather than effort, well‑designed plans can drive sustainable growth while poor designs can encourage short‑term behaviors that harm shareholder value.

Stock option financial

"Stock option award granted under the issuer's incentive compensation plan."

A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.

401(k) Plan Trustee financial

"By Issuer's 401(k) Plan Trustee"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What equity awards did Colgate-Palmolive (CL) grant to Betsy Fishbone on September 16, 2026?

On September 16, 2026, Betsy Fishbone received a stock option for 15,271 shares at an exercise price of $87.02 per share and a restricted stock unit award of 2,207 shares, both under Colgate-Palmolive’s incentive compensation plan.

How do the new restricted stock units for CL’s CLO vest?

The 2,207 restricted stock units granted to Colgate-Palmolive’s CLO vest in three equal installments on each of the first, second, and third anniversaries of the September 16, 2026 grant date.

When do the new stock options for Colgate-Palmolive (CL) become exercisable?

The 15,271-share stock option granted to the CLO becomes exercisable in one-third increments beginning on the first anniversary of the September 16, 2026 grant date and remains exercisable until September 16, 2036.

What are Betsy Fishbone’s direct common stock holdings in Colgate-Palmolive (CL) after these awards?

After the reported awards, Betsy Fishbone directly holds 16,050 shares of Colgate-Palmolive common stock, reflecting the addition of 2,207 restricted stock units reported as directly owned common stock.

What indirect Colgate-Palmolive (CL) holdings are reported for the CLO and Secretary?

Indirectly, the filing reports 50 shares of Colgate-Palmolive common stock held by a family member and 8,336 shares held by the issuer's 401(k) plan trustee for the benefit of the reporting person.

Was a Rule 10b5-1 trading plan involved in these CL insider transactions?

No. The filing indicates no Rule 10b5-1 trading plan for these transactions, which are reported as grant or award acquisitions under Colgate-Palmolive’s incentive compensation plan.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/18/2026 - 04:10 PM Accepted by SEC EDGAR 09/18/2026 - 04:09 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Fishbone Betsy

(Last) (First) (Middle)

C/O COLGATE-PALMOLIVE COMPANY

300 PARK AVENUE

(Street)

NEW YORK NEW YORK 10022

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
COLGATE PALMOLIVE CO [ CL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CLO and Secretary

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/16/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/16/2026		A(1)		2,207	A	$0.0000	16,050	D
Common Stock								50	I	By Family Member
Common Stock								8,336	I	By Issuer's 401(k) Plan Trustee

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$87.02	09/16/2026		A(2)		15,271		(3)	09/16/2036	Common Stock	15,271	$0.0000	15,271	D

Explanation of Responses:

1. Restricted stock unit award granted under the issuer's incentive compensation plan. The restricted stock unit award vests in equal 1/3 installments on each of the first, second and third anniversary of the date of grant.

2. Stock option award granted under the issuer's incentive compensation plan.

3. Option becomes exercisable in one-third increments beginning on the first anniversary of the September 16, 2026 grant date.

	/s/ Kristine Hutchinson, Attorney-in-Fact	09/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)